UCI Urology Team Developing Unique Endoscope to Improve Kidney Stone Surgery

UCI Urology (four Urologists), who specialize in kidney stone diseases include Dr. Pengbo Jiang, Dr. Jaime Landman, Dr. Roshan Patel, and Dr. Ralph V. Clayman, have teamed up with UCI CALIT2 engineers, Dr. William Mao, Dr. Mike Klopfer, and G. P. Li to design a new ureteroscope that is capable of removing all kidney stone fragments during surgery.

The team has six months to complete the project and has received a grant to develop the technology.

Uci Urology, Team Developing Unique Endoscope To Improve Kidney Stone Surgery
Uci Urology Team Developing Unique Endoscope To Improve Kidney Stone Surgery

Approximately 10% of the U.S. population will experience a kidney stone. The primary treatment goals are to remove the stone with the least amount of patient discomfort and to prevent recurrence. One of the least invasive options for surgery involves using a non-incisional approach by entering the urinary tract with a ureteroscope. This type of endoscopic approach allows the urologist to access a stone and use a laser to break the stone into fragments.

Unfortunately, with the current technology, many of the smallest fragments cannot be recovered and removed. In fact, with the ureteroscope, even the best stone clearance rates are no better than 50 to 60%. The remaining fragments (about 2mm or smaller in size) can contribute to the formation of recurring stones within two years in as many as 40% of patients.

The UCI team seeks to develop instrumentation that is able to leave the kidney fragment-free following stone removal. The team’s proposal has been awarded a UCI Beall Applied Innovation Proof of Product (POP) grant, a funding program that accelerates commercially promising technology.

Dr. Ralph Clayman stated, “The POP grant has empowered and energized our work in this area. I am optimistic that given the great partnership we have with CALIT2 and the School of Engineering, within six months we will have a working prototype. This work has the potential to vastly improve surgical outcomes for all patients with kidney stones.”

The team has six months to complete this project and will utilize the Surgical Education and Research Center located at UCI Medical Center, Orange, CA. If successful, a disposable ureteroscope will be created that is able to remove all stone fragments, regardless of size. The ureteroscope will have additional features designed to improve the efficiency and effectiveness of stone removal, such as multiple laser channels and multidirectional deflection.

UCI Urology is at the forefront of research, providing patients with the best in innovative and less invasive urologic care. The department has a core mission to discover new advances in healthcare, teach tomorrow’s medical professionals, and heal patients with individualized care.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The ArthroFree system is the first FDA-cleared wireless camera for arthroscopy and general endoscopy, both areas of minimally invasive surgery. The system is designed to help surgeons work with aximum dexterity and focus.
The project, which was led by the University of Southern California, included large increases in representation among men of African, Hispanic and Asian ancestries, that were contributed in part by an ongoing collaboration between the U.S. Department of Veterans Affairs and DOE reports Argonne.
This innovative software turns smartphones into medical-grade stethoscopes, allowing people to capture, analyze, and share critical heart health data with medical personnel from the comfort of any location notes Sparrow BioAcoustics.
"Taewoong Medical becoming an Olympus group company is also a major milestone in our global growth strategy," said Henry Shin, CEO of STARmed. "We look forward to our products being made available to more patients through Olympus' global distribution network."
The company reports they have successfully met the six-month primary endpoint for the first-ever female patient implanted with the UroActive™ System, the first smart automated artificial urinary sphincter (AUS) to treat SUI.

By using this website you agree to accept Medical Device News Magazine Privacy Policy